Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

Go back to Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

Accelerate Diagnostics (AXDX) Reports In-Line Q4 EPS

March 29, 2023 4:43 PM EDT

Accelerate Diagnostics (NASDAQ: AXDX) reported Q4 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $3 million versus the consensus estimate of $2.87 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

... More